# EDGAR Filing Document

**Accession Number:** 0000899460
**File Stem:** 0001193125-26-237183
**Filing Date:** 2026-5
**Character Count:** 5675
**Document Hash:** 1071b807bf478fddf0c20d385813990f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-237183.hdr.sgml**: 20260522

**ACCESSION NUMBER**: 0001193125-26-237183

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 9

**CONFORMED PERIOD OF REPORT**: 20260520

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20260522

**DATE AS OF CHANGE**: 20260522

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MANNKIND CORP
- **CENTRAL INDEX KEY:** 0000899460
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 133607736
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-50865
- **FILM NUMBER:** 261015078

**BUSINESS ADDRESS:**
- **STREET 1:** 1 CASPER STREET
- **CITY:** DANBURY
- **STATE:** CT
- **ZIP:** 06810
- **BUSINESS PHONE:** 818-661-5000

**MAIL ADDRESS:**
- **STREET 1:** 1 CASPER STREET
- **CITY:** DANBURY
- **STATE:** CT
- **ZIP:** 06810

?xml version='1.0' encoding='ASCII'? 8-K

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549**

------

## FORM 8-K

------

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported):** May 20, 2026<br>

------

MannKind Corporation

**(Exact name of Registrant as Specified in Its Charter)**

------

---

| | | |
|:---|:---|:---|
| Delaware | 000-50865 | 13-3607736 |
| **(State or Other Jurisdiction<br>of Incorporation)** | **(Commission File Number)** | **(IRS Employer<br>Identification No.)** |
| 1 Casper Street |  |  |
| Danbury**,** Connecticut |  | 06810 |
| **(Address of Principal Executive Offices)** |  | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code:** (818) 661-5000<br>

**(Former Name or Former Address, if Changed Since Last Report)**

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | |
|:---|:---|
| **<br>Title of each class** | **<br>Name of each exchange on which registered** |
| Common Stock, par value $0.01 per share<br> MNKD | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

## Item 5.07 Submission of Matters to a Vote of Security Holders.
The following is a brief description of each matter voted upon at our 2026 Annual Meeting of Stockholders held on May 20, 2026 (the "Annual Meeting"), as well as the number of votes with respect to each matter.

• Our stockholders elected each of the nine individuals nominated by our Board of Directors to serve as directors until the next annual meeting of stockholders. The tabulation of votes in the election was as follows:

---

| | | | |
|:---|:---|:---|:---|
| **Nominee** | **Shares <br>Voted For** | **Shares <br>Withheld** | **Broker<br> Non-Votes** |
| James S. Shannon | 142187528 | 12743525 | 78531407 |
| Michael E. Castagna | 142755974 | 12175079 | 78531407 |
| Steven B. Binder | 143496903 | 11434150 | 78531407 |
| Ronald J. Consiglio | 140083102 | 14847951 | 78531407 |
| Michael A. Friedman | 140598126 | 14332927 | 78531407 |
| Jennifer Grancio | 141763670 | 13167383 | 78531407 |
| Anthony Hooper | 142670402 | 12260651 | 78531407 |
| Sabrina Kay | 142178623 | 12752430 | 78531407 |
| Christine Mundkur | 143292686 | 11638367 | 78531407 |

---

• Our stockholders approved, on an advisory basis, the compensation of our named executive officers, as disclosed in our definitive proxy statement for the Annual Meeting, filed with the Securities and Exchange Commission on April 7, 2026. The tabulation of votes on this matter was as follows: shares voted for: 137,332,418; shares voted against: 16,295,138; shares abstaining: 1,303,497; and broker non-votes: 78,531,407.

• Our stockholders ratified the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. The tabulation of votes on this matter was as follows: shares voted for: 221,079,329; shares voted against: 8,759,982; shares abstaining: 3,623,149; and broker non-votes: 0.

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  |  | **MannKind Corporation** |
| Date: | May 22, 2026 | By:  | /s/ David Thomson, Ph.D., J.D. |
|  |  |  | David Thomson, Ph.D., J.D.<br>Executive Vice President, General Counsel and Secretary |

---

------